BioCentury | Apr 15, 2002
Regulation

Off-patent potential

...filgrastim G-CSF Anemia, leukemia, neutropenia Amgen 2013 2006 Proleukin IL-2 HIV Chiron 2012, 2007 2005 Streptase...
BioCentury | Nov 8, 1999
Clinical News

Streptokinase: Marketed

...occurred in 6 percent and 22 percent of the two groups, respectively. AstraZeneca plc markets Streptase...
Items per page:
1 - 2 of 2